NATALIA KHALAF to Pancreatic Neoplasms
This is a "connection" page, showing publications NATALIA KHALAF has written about Pancreatic Neoplasms.
Connection Strength
5.777
-
Emergency Presentations Predict Worse Outcomes Among Patients with Pancreatic Cancer. Dig Dis Sci. 2024 Feb; 69(2):603-614.
Score: 0.547
-
The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System. Pancreas. 2024 01 01; 53(1):e27-e33.
Score: 0.544
-
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Dig Dis Sci. 2023 09; 68(9):3634-3643.
Score: 0.532
-
Challenges and Opportunities in Pancreatic Cancer Screening Among High-Risk Individuals. Gastroenterology. 2022 06; 162(7):2113-2120.
Score: 0.486
-
New-onset Diabetes as a Signpost of Early Pancreatic Cancer: The Role of Screening. Clin Gastroenterol Hepatol. 2022 09; 20(9):1927-1930.
Score: 0.482
-
Why Do Small Intraductal Papillary Mucinous Neoplasms Create Such a Huge Management Challenge?: How International Classification of Diseases Codes Have Failed Us. Pancreas. 2022 02 01; 51(2):e13-e15.
Score: 0.481
-
Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin Gastroenterol Hepatol. 2021 05; 19(5):876-884.
Score: 0.421
-
Metabolic Alterations as a Signpost to Early Pancreatic Cancer. Gastroenterology. 2019 05; 156(6):1560-1563.
Score: 0.395
-
Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018 Aug; 53(8):959-966.
Score: 0.364
-
Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. Gastroenterology. 2018 04; 154(5):1380-1390.e5.
Score: 0.361
-
Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol. BMJ Open. 2024 01 22; 14(1):e079863.
Score: 0.138
-
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Nat Commun. 2023 07 18; 14(1):4317.
Score: 0.133
-
Prediagnostic Inflammation and Pancreatic Cancer Survival. J Natl Cancer Inst. 2021 09 04; 113(9):1186-1193.
Score: 0.117
-
Diabetes, Weight Change, and Pancreatic Cancer Risk. JAMA Oncol. 2020 10 01; 6(10):e202948.
Score: 0.110
-
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev. 2019 12; 28(12):2062-2069.
Score: 0.102
-
Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1868-1875.
Score: 0.101
-
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Br J Cancer. 2019 04; 120(8):848-854.
Score: 0.098
-
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet Med. 2019 01; 21(1):213-223.
Score: 0.094
-
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2018 Mar 08; 4(3):e173420.
Score: 0.092
-
Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. Clin Gastroenterol Hepatol. 2018 08; 16(8):1300-1306.e3.
Score: 0.091
-
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. Br J Cancer. 2017 Dec 05; 117(12):1874-1882.
Score: 0.089